Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia

Verfasser / Beitragende:
[Abhilasha Surampalli, Manaswitha Khare, Georgette Kubrussi, Marie Wencel, Jasmin Tanaja, Sandra Donkervoort, Kathryn Osann, Mariella Simon, Douglas Wallace, Charles Smith, Aideen M.McInerney-Leo, Virginia Kimonis]
Ort, Verlag, Jahr:
2015
Enthalten in:
Journal of Genetic Counseling, 24/5(2015-10-01), 842-850
Format:
Artikel (online)
ID: 605544808
LEADER caa a22 4500
001 605544808
003 CHVBK
005 20210128100933.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s10897-015-9819-7  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10897-015-9819-7 
245 0 0 |a Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia  |h [Elektronische Daten]  |c [Abhilasha Surampalli, Manaswitha Khare, Georgette Kubrussi, Marie Wencel, Jasmin Tanaja, Sandra Donkervoort, Kathryn Osann, Mariella Simon, Douglas Wallace, Charles Smith, Aideen M.McInerney-Leo, Virginia Kimonis] 
520 3 |a Inclusion Body Myopathy associated with Paget's disease of bone and Fronto-temporal Dementia, also known as multisystem proteinopathy is an autosomal dominant, late onset neurodegenerative disorder caused by mutations in Valosin containing protein (VCP) gene. This study aimed to assess uptake and decision making for predictive genetic testing and the impact on psychological well-being. Individuals who had participated in the gene discovery study with a 50 % a priori risk of inheriting VCP disease were sent a letter of invitation offering genetic counseling and testing and were also invited to participate in this psychosocial study. A total of 102 individuals received an invitation and 33 individuals participated in genetic counseling and testing (32.3 %) with 29 completing baseline questionnaires. Twenty completed the follow-up post-test Hospital Anxiety and Depression Scale questionnaire including 13 of the 18 who had tested positive. Mean risk perception at baseline was 50.1 %. Reasons for testing included planning for the future, relieving uncertainty, informing children and satisfying curiosity. At baseline, one quarter of the participants had high levels of anxiety. However, scores were normal one year following testing. In this small cohort, one third of individuals at 50 % risk chose pre-symptomatic testing. Although one quarter of those choosing testing had high anxiety at baseline, this was not evident at follow-up. 
540 |a National Society of Genetic Counselors, Inc., 2015 
690 7 |a Presymptomatic genetic testing  |2 nationallicence 
690 7 |a Huntington's disease  |2 nationallicence 
690 7 |a Neurodegenerative  |2 nationallicence 
690 7 |a Paget's disease  |2 nationallicence 
690 7 |a Hospital anxiety and depression scale  |2 nationallicence 
700 1 |a Surampalli  |D Abhilasha  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
700 1 |a Khare  |D Manaswitha  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
700 1 |a Kubrussi  |D Georgette  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
700 1 |a Wencel  |D Marie  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
700 1 |a Tanaja  |D Jasmin  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
700 1 |a Donkervoort  |D Sandra  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
700 1 |a Osann  |D Kathryn  |u Division of Hematology/Oncology, Department of Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
700 1 |a Simon  |D Mariella  |u Developmental and Cell Biology, University of California, 92697, Irvine, CA, USA  |4 aut 
700 1 |a Wallace  |D Douglas  |u Developmental and Cell Biology, University of California, 92697, Irvine, CA, USA  |4 aut 
700 1 |a Smith  |D Charles  |u Department of Neurology and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA  |4 aut 
700 1 |a M.McInerney-Leo  |D Aideen  |u The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia  |4 aut 
700 1 |a Kimonis  |D Virginia  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
773 0 |t Journal of Genetic Counseling  |d Springer US; http://www.springer-ny.com  |g 24/5(2015-10-01), 842-850  |x 1059-7700  |q 24:5<842  |1 2015  |2 24  |o 10897 
856 4 0 |u https://doi.org/10.1007/s10897-015-9819-7  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10897-015-9819-7  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Surampalli  |D Abhilasha  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Khare  |D Manaswitha  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kubrussi  |D Georgette  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Wencel  |D Marie  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tanaja  |D Jasmin  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Donkervoort  |D Sandra  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Osann  |D Kathryn  |u Division of Hematology/Oncology, Department of Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Simon  |D Mariella  |u Developmental and Cell Biology, University of California, 92697, Irvine, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Wallace  |D Douglas  |u Developmental and Cell Biology, University of California, 92697, Irvine, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Smith  |D Charles  |u Department of Neurology and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a M.McInerney-Leo  |D Aideen  |u The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kimonis  |D Virginia  |u Department of Pediatrics, Division of Genetics and Genomic Medicine, University of California, 92697, Irvine, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Journal of Genetic Counseling  |d Springer US; http://www.springer-ny.com  |g 24/5(2015-10-01), 842-850  |x 1059-7700  |q 24:5<842  |1 2015  |2 24  |o 10897